Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826860 · ClinicalTrials.gov registry record · NA
Storytelling and Mindfulness for Graduate Student Wellbeing
A NA study of Depression and Anxiety, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05826860: Recruiting NA study of Depression and Anxiety, sponsored by University of Wisconsin, Madison.
NCT05826860 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05826860, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate an intervention for improving Science, Technology, Engineering, and Math (STEM) graduate student wellbeing. Participants will be recruited from the University of Wisconsin-Madison graduate student body. Data will be collected from participants for up to 2 years, and the investigators anticipate that the study will last for 4 years.
Primary Outcome
This survey is a measure of environmental, interpersonal, and self-awareness. It is a 39-item self-report questionnaire rated on a 1 to 5 scale from 1 (never or very rarely true) to 5 (very often or always true). Mean score from 1-5 is reported with higher scores indicating increased mindfulness.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Practice
- BEHAVIORAL Storytelling Workshop
Study Locations (1)
Wisconsin
- Wisconsin Institute for Discovery - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-10 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT05826860 shows while recruiting
NCT05826860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Practice is the first listed.
NCT05826860 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05826860 about?
NCT05826860 is a clinical study titled "Storytelling and Mindfulness for Graduate Student Wellbeing". The purpose of this study is to evaluate an intervention for improving Science, Technology, Engineering, and Math (STEM) graduate student wellbeing. Participants will be recruited from the University of Wisconsin-Madison graduate student body. Data will be collected from participants for up to 2 yea...
What is the current status of trial NCT05826860?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-03-10. Estimated completion is 2027-05.
What conditions does trial NCT05826860 study?
This clinical trial studies the following conditions: Depression, Anxiety, Burnout, Student.
What interventions are being tested in trial NCT05826860?
The interventions under investigation include: Mindfulness Practice (BEHAVIORAL), Storytelling Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT05826860?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05826860 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05826860's enrollment target sits among peer trials
20 612th of 679 higher than 58 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy